Latest filing published 23 Jun 2022 for Outlook Therapeutics, Inc., €20k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +45.0%Entry US$21.80 · Close at T+365 US$31.60
- -32.2%Entry US$29.80 · Close at T+365 US$20.20
- -21.8%Entry US$26.60 · Close at T+365 US$20.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
C. Russell Trenary III: trading record in brief
This profile gathers the share dealings of C. Russell Trenary III across 2 companies, led by Advanced Medical Optics Inc and Outlook Therapeutics, Inc. In total, 37 filings cover trades dated from 16 February 2006 to 21 June 2022.
In open-market terms, that means 3 purchases worth €63k on one side and 5 sales worth €1.9M on the other. Sales outweigh purchases by €1.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 16 share grants and 5 option exercises. In 2022 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €20k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +23.5%. This is a record of the past, not a forecast.
On 23 June 2022 came the latest disclosure, an open-market purchase for €20k in Outlook Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to C. Russell Trenary III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,925 shares@ US$1.060.014% mcap31.7% of flowCommon StockSEC:0001209191-22-038985:0Canonical exit: 19 Sept 2022 (T+90)
- 25,000 shares@ US$1.3948.7% of flowCommon StockSEC:0001209191-21-068137:0Canonical exit: 6 Mar 2022 (T+90)
- 10,000 shares@ US$1.4019.6% of flowCommon StockSEC:0001209191-21-067644:0Canonical exit: 2 Mar 2022 (T+90)
- 1,879 shares0Common StockSEC:0001256928-09-000009:11
- 7,699.68 shares@ US$22.00Common StockSEC:0001256928-09-000009:0
- 759.61 shares@ US$22.00Common StockSEC:0001256928-09-000009:1
- 496 shares0Common StockSEC:0001256928-09-000009:2
- 227 shares@ US$22.01Common StockSEC:0001256928-09-000009:3
- 269 shares@ US$22.00Common StockSEC:0001256928-09-000009:4
- 2,540 shares0Common StockSEC:0001256928-09-000009:5
- 3,451 shares0Common StockSEC:0001256928-09-000009:8
- 1,579 shares@ US$22.01Common StockSEC:0001256928-09-000009:9
- 1,872 shares@ US$22.00Common StockSEC:0001256928-09-000009:10
- 860 shares@ US$22.01Common StockSEC:0001256928-09-000009:12
- 1,019 shares@ US$22.00Common StockSEC:0001256928-09-000009:13
- 1.52 shares@ US$22.00Common StockSEC:0001256928-09-000009:14
- 57,000 shares@ US$8.99Common StockSEC:0001256928-09-000005:0
- 57,000 shares@ US$21.97Common StockSEC:0001256928-09-000005:1
- 30,000 shares@ US$13.85Common StockSEC:0001256928-09-000005:2
- 30,000 shares@ US$21.97Common StockSEC:0001256928-09-000005:3
- 1,092 shares@ US$6.29Common StockSEC:0001256928-09-000004:1
- 4,360 sharesCommon StockSEC:0001256928-09-000004:2
- 3,849 sharesCommon StockSEC:0001256928-09-000004:4
- 1,377 shares@ US$6.29Common StockSEC:0001256928-09-000004:5
- 721 sharesCommon StockSEC:0001256928-09-000004:6
25 of 34 declarations
